Table 2.
LYG, Total costs and ICER for PCV13, PCV10 and no vaccination in Colombian children younger than 5 years, 2014
| No vaccine | PCV10 | PCV13 | |
|---|---|---|---|
| Total discounted LYG | 0 | 18 708 | 25 396 |
| Discounted medical costs avoided | 0 | $ - 13 703 271 | $ - 19 479 395 |
| Vaccine costs* | 0 | $ 28 920 564 | $ 31 904 432 |
| Total costs | 0 | $ 15 217 293 | $ 12 425 037 |
| C/E Prevented cases (per additional LYG) | $ 813.41 | $ 489.26 | |
| Incremental analysis | |||
| ICER No Vaccine vs. PCV10 | $ 813.41 | ||
| ICER PCV10 vs. PCV13 | $ - 417.53 |
*Included administration costs.
LYG: Life Years Gained.
C/E: Cost-effectiveness ratio.